|
Kindeva, a global contact development and manufacturing organization, was joined by Lieutenant Governor Jacqueline Coleman and community leaders on May 1st to mark a key milestone in the company’s continued investment in Kentucky.
A ribbon-cutting ceremony held at Kindeva’s Lexington facility celebrated the site’s full integration into the organization’s global network and its growing role in advancing nasal drug delivery innovation. Now fully aligned with Kindeva’s global operations, the Lexington facility strengthens the company's ability to support biopharmaceutical partners with specialized drug delivery solutions across nasal, transdermal, injectable, and inhalation platforms.
Commerce Lexington President and CEO, Bob Quick, said, “We are excited to celebrate this great success story for our region. Greater Lexington is an expanding biotech and life sciences hub because of companies like Kindeva, which has harnessed global manufacturing and R&D facilities to develop innovative solutions for the future of drug delivery. This expansion will enable Kindeva to leverage Summit Biosciences’ strong track record in the nasal spray market. We appreciate Kindeva’s confidence in and commitment to the Lexington region.”
|